Health Canada approves darolutamide for metastatic castration-sensitive prostate cancer
prostate cancer, metastatic castration-sensitive prostate cancer, darolutamide, androgen deprivation therapy, radiographic progression-free survival, overall survival, safety, treatment-emergent ad...